News
Hosted on MSN1mon
FDA approves ARS’ neffy 1mg for paediatric anaphylaxisThe US Food and Drug Administration (FDA) has approved ARS Pharmaceuticals' neffy 1mg (epinephrine nasal spray) for treating type one allergic reactions including anaphylaxis in paediatric ...
neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...
Thus, all facilities that perform procedures requiring the use of EPINEPHrine 1 mg/mL (1:1000) for topical application should review their processes and consider the following recommendations.
July 29, 2004) has further highlighted ongoing serious problems with epinephrine labeling and nomenclature ... concentrations (such as 1:1,000 or 1 mg/mL and 1:10,000 or 0.1 mg/mL), and (2 ...
Epinephrine 0.1mg, 0.15mg, 0.3mg; pre-filled auto-injector (includes audible and visible cues for use). <7.5kg: not established. Inject IM or SQ only into the anterolateral aspect of the thigh.
Hosted on MSN1mon
ARS Pharmaceuticals outlines 2025 growth strategy with neffy commercialization and global expansionCEO Lowenthal stated that the pediatric 1mg dose could significantly impact sales, given its target demographic. Alexa Deemer of Cantor Fitzgerald inquired about the epinephrine market ...
Lidocaine HCl 5mg/mL with epinephrine 1:200000, 10mg/mL with epinephrine 1:100000, 20mg/mL with epinephrine 1:100000; soln; contains methylparaben, sodium metabisulfite. See full labeling for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results